• Profile
Close

Clinical features and molecular epidemiology of diarrheagenic Escherichia coli pathotypes identified by fecal gastrointestinal multiplex nucleic acid amplification in patients with cancer and diarrhea

Diagnostic Microbiology and Infectious Disease Aug 29, 2017

Chao A, et al. – At a major cancer center in the U.S., researchers determined clinical features and molecular epidemiology of diarrheagenic Escherichia coli pathotypes identified by fecal gastrointestinal multiplex nucleic acid amplification in patients with cancer and diarrhea. In this study, while in some instances Biofire FilmArray multiplex GI panel (BFM) results were not verified in culture and could represent false positives, diarrheagenic Escherichia coli (DEC) pathotypes, especially Enteropathogenic E. coli (EPEC) and enteroaggregative E. coli (EAEC), caused chronic infections with antimicrobial–resistant strains in a subset of immunosuppressed cancer patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay